Characteristics of ICI+PMR compared with ICI−PMR
| ICI+PMR (n=14) | ICI−PMR (n=43) | |
| Women (%) | 2 (14.3) | 26 (39.5) |
| Patients over 50 years old (%) | 13 (92.9) | 40 (93) |
| Peripheral arthritis (%) | 8 (57.1) | 12 (27.9) |
| CRP >5 mg/L (%) | 12/13 (92.3) | 37/42 (88.1) |
| Median CRP (mg/L) | 69 (<5–150) | 32 (6–170) |
| GCs sensitivity (excluding high-dose steroid–dependent patients) (%) | 8/13 (61.5) | – |
CRP, C reactive protein; GC, glucocorticoids; ICI, immune checkpoint inhibitor; PMR, polymyalgia rheumatica.